-
Menarini Silicon Biosystems Develops New Assay Workflow for Circulating Multiple Myeloma Cells
Mar 5, 2019, 10:46 AM by Michael CroftHUNTINGDON VALLEY, PA, UNITED STATES - Mar 5, 2019 - Menarini Silicon Biosystems, the pioneer of liquid biopsy technology, announced today that it will introduce a new semi-automated assay workflow utilizing the CELLSEARCH® and DEPArrayTM platforms to enumerate and characterize circulating multiple myeloma cells (CMMC) from peripheral blood samplesFull story -
Centers for Disease Control and Prevention (CDC) Selects Certara to Develop Technology Platform to Strengthen the Agency’s Death Investigation and Surveillance Systems
Mar 5, 2019, 10:14 AM by Michael CroftPRINCETON, NJ - Mar 5, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced that the US Centers for Disease Control & Prevention (CDC) has awarded it a contract to strengthen the Agencys death investigation and surveillance systemsFull story -
Procarta announces €1.5 million investment for new class of antibiotics to combat antimicrobial resistance
Mar 5, 2019, 05:04 AM by Michael CroftSTEVENAGE, UK - Mar 5, 2019 - Procarta Biosystems, a privately held UK-based biotech company, today announced €1.5m of new funding from the Novo Holdings REPAIR Impact Fund to support development of novel therapies to combat antimicrobial resistance (AMR)Full story -
BOC Sciences Has Updated Its API Synthesis by Joining Intermediates Synthesis Service
Mar 4, 2019, 01:19 AM by Michael CroftSHIRLEY, NY - Mar 4, 2019 - BOC Sciences, a US-based global manufacturer of high-quality chemicals and efficient custom services to support the pharmaceutical industry through all stages of drug discovery, has recently added intermediates synthesis to its API synthesis portfolioFull story -
BINDING SITE OFFERS NATIVE BORDETELLA PERTUSSIS ANTIGENS FOR RESEARCH & IVD MANUFACTURING APPLICATIONS
Mar 1, 2019, 14:50 PM by Michael CroftSAN DIEGO, CA - Mar 1, 2019 - BINDING SITE'sImmunologicals Group is pleased to announce the addition of three (3) new native Bordetella pertussis antigens to its broad offering of products for in-vitro diagnostic (IVD) manufacturing and research applicationsFull story -
Recipharm achieves new ISO 45001 certification to support sustainability efforts
Mar 1, 2019, 09:44 AM by Michael Croft- Mar 1, 2019 - Recipharm, the contract development and manufacturing organisation (CDMO), has achieved the new ISO 45001 certification at its Wasserburg facility in GermanyFull story -
Creative Biolabs Releases One-stop Vaccine Development Services
Feb 28, 2019, 05:09 AM by Michael CroftSHIRLEY, NY - Feb 20, 2019 - As a leading service provider that focuses on vaccines fields, Creative Biolabs now releases comprehensive one-stop vaccine development services to help researchers and vaccine companies to reduce the cost of failure and increase the chance of clinical successFull story -
Rare disease repurposing datathon from Elsevier and The Pistoia Alliance reveals five new candidates for potential treatment of chronic pancreatitis
Feb 28, 2019, 04:03 AM by Michael Croft, NY - Feb 28, 2019 - Rare Disease Day - A unique non-profit and private partnership using a datathon and an AI-powered technology platform has identified five repurposable drug candidates to treat a painful chronic disease affecting about a million people globally and for which there is no current treatmentFull story -
TARGET PharmaSolutions® to Advance Dermatology Research, including Atopic Dermatitis, through New Collaboration
Feb 27, 2019, 13:45 PM by Michael CroftDURHAM, NC - Feb 27, 2019 - TARGET PharmaSolutions, Inc., a real-world clinical data solutions company, is pleased to announce that Novartis Pharma AG is the first industry partner to provide multi-year support to TARGET-DERM registry TARGET-DERM is a global longitudinal observational study that evaluates adult and pediatric patients with immune-mediated inflammatory skin conditions (IMISCs)Full story -
China Unveils New Rules On Biotech After Gene-Editing Scandal
Feb 27, 2019, 10:08 AM by Michael CroftSTAT | China has unveiled draft regulations on gene editing and other potentially risky biomedical technologies after a Chinese scientist's claim of helping to create gene-edited babies roiled the global science community.Full story -
Illumina, VAST Data, Thermo Fisher Scientific, And More: News From February 2019
Feb 27, 2019, 09:25 AM by Michael CroftFull storyBio-IT World | February featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Illumina, VAST Data, Thermo Fisher Scientific, and more.
-
MR Solutions’ high-field multi-modality, cryogen-free MRI system on display at EMIM
Feb 27, 2019, 06:32 AM by Michael CroftGUILDFORD, UNITED KINGDOM - Feb 27, 2019 - MR Solutions latest compact preclinical, multi-modality MRI systems will be on display at the 14th European Molecular Imaging Meeting (EMIM 2019) being held at the Scottish Event Campus in Glasgow on 19 to 22 March, 2019Full story -
CRF Bracket Grows More in First Quarter Together than Either Company Achieved Alone in 2018
Feb 27, 2019, 03:59 AM by Michael CroftPHILADELPHIA, PA - Feb 27, 2019 - CRF Bracket recently closed its first full quarter as a combined business after CRF Health and Bracket merged in September of 2018Full story -
ActiveRADAR Adds Seasoned Managed Care Pharmacy Pioneer, Norrie Thomas, Ph.D. M.S., R.Ph, to Board of Directors
Feb 26, 2019, 10:03 AM by Michael CroftSACRAMENTO, CA, UNITED STATES - Feb 26, 2019 - ActiveRADAR, a company specializing in pharmacy cost reduction programs for employers, trust funds and health plans, today announced that Norrie Thomas, PhFull story -
Lundbeck selects Reaxys and Reaxys Medicinal Chemistry to improve internal and external data integration and access
Feb 26, 2019, 05:04 AM by Michael Croft, NY - Feb 26, 2019 - Elsevier, the information analytics business specializing in science and health, announced today that Lundbeck, the global pharmaceutical company specializing in brain diseases, has selected Elseviers Reaxys and Reaxys Medicinal Chemistry (RMC) to support the ambitions of its Research organization and accelerate data sharing and miningFull story -
PacBio Generates Accurate Long Read Sequences Through Circular Consensus Sequencing
Feb 25, 2019, 10:10 AM by Michael CroftFull storyBio-IT World | PacBio has developed a protocol based on single-molecule, circular consensus sequencing to generate accurate long read sequences. The company hopes this approach will provide an alternative to the limited read lengths of short read sequencing and the limited read accuracy of long read sequencing.
-
Lygos Partners with Leading Materials Scientists at the University of Massachusetts to Expand Applications of its Bio-Malonic™ Acid Product Family
Feb 21, 2019, 13:44 PM by Michael CroftBERKELEY, CA, UNITED STATES - Feb 20, 2019 - Lygos Inc., a full-stack producer of petroleum-free specialty chemicals that deliver high-value performance without the environmental toxicity, today announced a new partnership with the Center for University of Massachusetts-Industry Research on Polymers (CUMIRP), the nations oldest National Science Foundation Industry / University Cooperative Research Center dedicated to polymer researchFull story -
D4
Feb 21, 2019, 10:43 AM by Michael CroftBOSTON, MA - Mar 20, 2019 - This is the first conference to specifically help pharma and biotech companies build and execute a scalable, sustainable and future-resistant R&D data strategy, including innovative yet accessible new approaches, methods and ways of looking at the data life cycle that drive incredible value within pharma R&DxFull story -
The Imperative For Open Data Access And Sharing: A Progress Report
Feb 21, 2019, 09:30 AM by Michael CroftFull storyBio-IT World Contributed Commentary | Clinical data sharing creates new value, with benefits to science and society. There has been a great deal of activity, which is a positive step, yet current approaches are somewhat fragmented in terms of process and openness.
-
Linum Labs announces Molecule, a software platform and marketplace to accelerate innovation in pharma
Feb 21, 2019, 08:22 AM by Michael Croft- Feb 21, 2019 - Linum Labs, a software development studio that builds blockchain-based solutions, has announced Molecule, a market platform to accelerate innovation in the pharmaceutical and biotech industryFull story